These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1762122)

  • 1. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Current summary of lymphocyte survival study.
    Nakamura N; Akiyama M; Kyoizumi S; Kusunoki Y
    J Radiat Res; 1991 Mar; 32 Suppl():327-9. PubMed ID: 1762122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose survival of G0 lymphocytes irradiated in vitro: a test for a possible population bias in the cohort of atomic bomb survivors exposed to high doses.
    Nakamura N; Sposto R; Akiyama M
    Radiat Res; 1993 Jun; 134(3):316-22. PubMed ID: 8316624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Radiation cataract.
    Otake M; Schull WJ
    J Radiat Res; 1991 Mar; 32 Suppl():283-93. PubMed ID: 1762117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation-related posterior lenticular opacities in Hiroshima and Nagasaki atomic bomb survivors based on the DS86 dosimetry system.
    Otake M; Schull WJ
    Radiat Res; 1990 Jan; 121(1):3-13. PubMed ID: 2300666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The F value for chromosome aberrations in atomic bomb survivors does not provide evidence for a primary contribution of neutrons to the dose in Hiroshima.
    Kodama Y; Ohtaki K; Awa AA; Nakano M; Itoh M; Nakamura N
    Radiat Res; 1999 Nov; 152(5):558-62. PubMed ID: 10521934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Theoretical background of the Dosimetry System 86 (D586).
    Kosako T
    J Radiat Res; 1991 Mar; 32 Suppl():11-9. PubMed ID: 1762097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is interindividual variation of cellular radiosensitivity real or artifactual?
    Nakamura N; Sposto R; Kushiro J; Akiyama M
    Radiat Res; 1991 Mar; 125(3):326-30. PubMed ID: 2000457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thermoluminescence dosimetry of gamma rays using ceramic samples from Hiroshima and Nagasaki: a comparison with DS86 estimates.
    Nagatomo T; Ichikawa Y; Hoshi M
    J Radiat Res; 1991 Mar; 32 Suppl():48-57. PubMed ID: 1762131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiosensitivity of atomic bomb survivors as determined with a micronucleus assay.
    Ban S; Cologne JB; Fujita S; Awa AA
    Radiat Res; 1993 May; 134(2):170-8. PubMed ID: 8488251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. The Dosimetry System 1986 (DS86) and the Tentative Dosimetry System 1965 (T65D): how do they compare, what is left to do?
    Thiessen JW; Kaul DC
    J Radiat Res; 1991 Mar; 32 Suppl():1-10. PubMed ID: 1762093
    [No Abstract]   [Full Text] [Related]  

  • 11. Workshop Report on Atomic Bomb Dosimetry--Review of Dose Related Factors for the Evaluation of Exposures to Residual Radiation at Hiroshima and Nagasaki.
    Kerr GD; Egbert SD; Al-Nabulsi I; Bailiff IK; Beck HL; Belukha IG; Cockayne JE; Cullings HM; Eckerman KF; Granovskaya E; Grant EJ; Hoshi M; Kaul DC; Kryuchkov V; Mannis D; Ohtaki M; Otani K; Shinkarev S; Simon SL; Spriggs GD; Stepanenko VF; Stricklin D; Weiss JF; Weitz RL; Woda C; Worthington PR; Yamamoto K; Young RW
    Health Phys; 2015 Dec; 109(6):582-600. PubMed ID: 26509626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid Dysfunction and Autoimmune Thyroid Diseases Among Atomic Bomb Survivors Exposed in Childhood.
    Imaizumi M; Ohishi W; Nakashima E; Sera N; Neriishi K; Yamada M; Tatsukawa Y; Takahashi I; Fujiwara S; Sugino K; Ando T; Usa T; Kawakami A; Akahoshi M; Hida A
    J Clin Endocrinol Metab; 2017 Jul; 102(7):2516-2524. PubMed ID: 28472357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic cell mutations in atomic bomb survivors.
    Akiyama M; Nakamura N; Hakoda M; Kyoizumi S; Kushiro J; Hirai Y; Kusunoki Y
    J Radiat Res; 1991 Mar; 32 Suppl():278-82. PubMed ID: 1762116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atomic bomb and leukemia.
    Ichimaru M; Tomonaga M; Amenomori T; Matsuo T
    J Radiat Res; 1991 Dec; 32 Suppl 2():14-9. PubMed ID: 1823351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-ray sensitivity of fibroblast cell strains derived from atomic bomb survivors with and without breast cancer.
    Ban S; Setlow RB; Ezaki H; Hiraoka T; Yamane M; Nishiki M; Dohi K
    J Radiat Res; 1991 Mar; 32 Suppl():330-8. PubMed ID: 1762123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longevity of atomic-bomb survivors.
    Cologne JB; Preston DL
    Lancet; 2000 Jul; 356(9226):303-7. PubMed ID: 11071186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of radiation doses for atomic-bomb survivors in the Hiroshima University Registry.
    Hoshi M; Matsuura M; Hayakawa N; Ito C; Kamada N
    Health Phys; 1996 May; 70(5):735-40. PubMed ID: 8690587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Cancer risk among in utero-exposed survivors.
    Yoshimoto Y; Kato H; Schull WJ
    J Radiat Res; 1991 Mar; 32 Suppl():231-8. PubMed ID: 1762110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Summary and conclusions.
    Abrahamson S
    J Radiat Res; 1991 Mar; 32 Suppl():395-412. PubMed ID: 1762129
    [No Abstract]   [Full Text] [Related]  

  • 20. Persistent chromosome aberrations in the somatic cells of A-bomb survivors, Hiroshima and Nagasaki.
    Awa AA
    J Radiat Res; 1991 Mar; 32 Suppl():265-74. PubMed ID: 1762114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.